Schisandrin B is shown to have protective effects against Alzheimer’s disease in cell model via regulating DNMT3A and DNMT1 mRNA expression then influence the DNA methylation level. Here, DNMT3A is linked to early-onset autosomal dominant Alzheimer disease.